Translation of scientific bench-top discoveries into a commercial enterprise can be one of the hardest transitions for academic groups. Additionally, there are very few therapeutic options for neurodegenerative diseases, and a great need exists for the development of new drug candidates to treat diseases, such as amyotrophic lateral sclerosis. Our proposal seeks to continue with […]
Read More